TA
GILD icon

TKG Advisors’s Gilead Sciences GILD Stock Holding History

TKG Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-46,526
Closed -$5.71M – 94
2025
Q4 		$5.71M Buy
46,526
+763
+2% +$92.7K 2.3% 12
2025
Q3 		$5.08M Sell
45,763
-717
-2% -$81.5K 2.18% 17
2025
Q2 		$5.15M Buy
+46,480
New +$4.95M 2.31% 16

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

TKG Advisors's GILD Position: Q1 2026 in Review

TKG Advisors sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 46,526 shares — an estimated $5.71M sold.

TKG Advisors first reported a position in GILD in Q2 2025 and held it in 3 quarters. The position peaked at $5.71M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • TKG Advisors reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • TKG Advisors sold 46,526 Gilead Sciences shares in Q1 2026, an estimated $5.71M.
  • TKG Advisors first reported a position in Gilead Sciences in Q2 2025 and held it in 3 quarters.
  • TKG Advisors's Gilead Sciences position peaked at $5.71M in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on TKG Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.